Polaris Market Research recently published [115+ Pages] research report on “Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2022 – 2030” in its research database.
According to the research report, the global monoclonal antibodies in veterinary health market size & share was valued at 680.6 million in 2021 and is expected to reach USD 2,629.6 Million by 2030, growing at a CAGR of 16.8% during the forecast period.
The monoclonal antibody is an antibody brought out by a single clone of cells or cell lines and contains an identical antibody molecule. These antibodies are used in the animal world, majorly in research, to track milk formation throughout the time of lactation, to refine substances, and recognize the origin and evolution of many disease-producing agents, that includes the function of specific proteins and enzymes in cancer.
Furthermore, the animal health market accounts for the food producing, large animals that include beef & dairy cattle, swine, sheep, and poultry. The rising frequency of atopic dermatitis and growing pet adoption are the key factors uplifting the monoclonal antibodies in veterinary health market share during the assessment period.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Key Highlights of the Report
- The complete analysis includes an assessment of the rising market.
- A study about growth opportunities in key segments and regions.
- Crucial modifications in industry dynamics.
- Overall company profiling of leading players in the market.
- Authentic industry value chain and supply chain analysis.
- Directions to the company for strengthening its presence in the industry.
Some of the Top Market Players Are:
- Adivo GmbH
- Bayer Animal Health
- Boehringer Ingelheim GmbH
- Elanco; Indian Immunologicals Ltd.
- Kindred Biosciences Inc.
- Merck & Co. Inc
To Know Additional Information on Market Players, Download Sample PDF Brochure
Growth Driving Factors
- Rising pet expenditure accelerates the demand
The monoclonal antibodies in veterinary health market demand are rising due to the requirement of preferable companion animal treatment choices being managed by a growing number of pet owners, which dominates the cost of pet healthcare. The growing rate of pets is uplifting the demand for more productive therapies, which is anticipated to propel the industry’s growth. Additionally, rising government and private initiatives towards health initiatives and, majorly, cancer treatment are fuelling the market growth.
Moreover, rising pet expenditure accelerates the demand for more productive therapeutics, which is expected to drive the global industry. Also, rising research and development activities by the leading market players for the expansion of cancer treatments are predicted to grow the monoclonal antibodies in veterinary health market size over the assessment period. The rising frequency of canine atopic dermatitis is estimated to grow at a considerable rate.
Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/15611
- April 2019: Bayer Animal Health GmbH and adivo GmbH has been signed a global collaboration agreement to develop therapeutic antibodies for veterinary medicine.
- Aug 2021: Elanco Announces Agreement to Acquire Kindred Biosciences. The transaction includes three potential blockbusters in the development phase, fulfills the current pipeline, and strengthens the R&D capabilities for monoclonal antibodies.
- The dog segment is considered the largest revenue share
On the basis of animal type, the dog segment accounted for the highest monoclonal antibodies in veterinary health market share in 2021. This is due to the growing frequency of several chronic diseases in animals, and increasing acceptance of pet insurance features are propelling the market share. Also, the other segment covers animals that include horses, cats, and livestock.
- The dermatology segment accounted for the largest revenue share
On the basis of application, the dermatology segment dominated the industry in 2021. Due to the rising frequency of dermatology diseases such as fleas & ticks also, allergic dermatitis is anticipated to uplift the industry growth. The majorly determined dermatological conditions are surface pyoderma, allergies, otitis externa, and seborrheic dermatitis.
- The veterinary hospital segment dominated the market
Based on the end user, the monoclonal antibodies in veterinary health market segmentations are divided into veterinary hospitals and others. The veterinary hospital’s segment and several veterinarians positively influence the market growth. Due to the existence of new therapies, this segment dominated the industry.
Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-discount-pricing
Monoclonal Antibodies in Veterinary Health Market: Report Scope
|Market Outlook for 2030||USD 2,629.6 Million|
|Market Size 2021 Value||USD 680.6 Million|
|Expected CAGR Growth||16.8% from 2022 – 2030|
|Forecast Year||2022 – 2030|
|Top Market Players||Adivo GmbH, Bayer Animal Health, Boehringer Ingelheim GmbH, Elanco; Indian Immunologicals Ltd., Invetx, Kindred Biosciences, Inc., Merck & Co. Inc, Nextmune, Virbac, Zoetis|
|Segments Covered||By Animal Type, By Application, By End-Use, and By Region|
|Customization Options||Customized purchase options are available to meet your research needs. Explore customized purchase options|
- North America held a significant market share
On a geographical basis, the North American region dominated the monoclonal antibodies in veterinary health market in 2021. This is due to the rising government and private initiatives towards the industry and increasing adoption of pet insurance. The leading industry players in these regions are also propelling industry growth.
Moreover, the Asia Pacific region is driving the market, owing to the increasing number of local competitors & veterinary hospitals and clinics. Also, the industry is expected to boost due to the rising adoption of pets, growing knowledge of their illnesses, and the availability of fluctuating forms of therapy.
Browse the Detail Report “Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market
For Additional Information OR Media Enquiry, Please Mail Us At: firstname.lastname@example.org
Key Questions Answered in The Report Include:
- What are the major opportunities covered in the market?
- What will be the growth rate during the foreseen period?
- Which segment and region will have the highest growth?
- What are the factors propelling the industry?
- What is the competitive outlook of the market?
- What is the role of leading players in the value chain?
Polaris Market Research has segmented the monoclonal antibodies in veterinary health market report based on animal type, application, end-user, and region:
By Animal Type Outlook
By Application Outlook
By End-Use Outlook
- Veterinary Hospitals
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
30 Wall Street
New York City, NY 10005,
Phone: +1-929 297-9727